pCFB-EGSH Retroviral Vector
Agilent Technologies Dose-responsive inducible mammalian expression  Induction as high as 1,700 fold  Tightly repressed  Novel IRES site allows expression of both receptor subunits from the same CMV promoter  Retroviral and plasmid gene delivery systems available  Stable receptor cell lines available









